Literature DB >> 324372

BCG as adjuvant immunotherapy for neoplasia.

E M Hersh, J U Gutterman, G M Mavligit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324372     DOI: 10.1146/annurev.me.28.020177.002421

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  17 in total

1.  Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique.

Authors:  K K Kwok; M J Groves; D J Burgess
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma.

Authors:  J W Millar; P Roscoe; S J Pearce; S Ludgate; N W Horne
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

3.  A novel method for determination of sterility of microcapsules and measurement of viability of encapsulated organisms.

Authors:  K K Kwok; D J Burgess
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

4.  In vitro analysis of cancer prevention by a mycobacterial antigen complex and of cancer-promoted inhibition of immune reactions.

Authors:  H Maes; C Cocito
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Recombinant BCGs for tuberculosis and bladder cancer.

Authors:  Alok K Singh; Geetha Srikrishna; Trinity J Bivalacqua; William R Bishai
Journal:  Vaccine       Date:  2021-09-27       Impact factor: 3.641

6.  Elevated adjuvanticity of non-acid-fast mycobacteria.

Authors:  Y Kondo; T Toida
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  Effect of BCG on the resistance of rats to infection with Fasciola hepatica.

Authors:  R C Thompson; M J Howell
Journal:  Z Parasitenkd       Date:  1979

8.  Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG.

Authors:  J Tai; A Guclu; T Ghose; S Norvell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  The enhancement of tetrathyridial proliferation of Mesocestoides corti in mice by B.C.G.

Authors:  R C Thompson; W J Penhale
Journal:  Z Parasitenkd       Date:  1978-07-04

Review 10.  'Trained immunity': consequences for lymphoid malignancies.

Authors:  Wendy B C Stevens; Mihai G Netea; Arnon P Kater; Walter J F M van der Velden
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.